Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9091 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.898 |
High Similarity |
NPD2534 |
Approved |
0.898 |
High Similarity |
NPD2532 |
Approved |
0.898 |
High Similarity |
NPD2533 |
Approved |
0.8882 |
High Similarity |
NPD7819 |
Suspended |
0.8725 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8608 |
High Similarity |
NPD6232 |
Discontinued |
0.86 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD3750 |
Approved |
0.8456 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8447 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8428 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8397 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8387 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8377 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8356 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8323 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8291 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8289 |
Intermediate Similarity |
NPD1511 |
Approved |
0.828 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8267 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8261 |
Intermediate Similarity |
NPD5711 |
Approved |
0.8261 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8255 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8255 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8243 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8232 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8228 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8217 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.82 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8188 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8188 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8188 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1512 |
Approved |
0.817 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8165 |
Intermediate Similarity |
NPD2801 |
Approved |
0.816 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8113 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8101 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8089 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8082 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8013 |
Intermediate Similarity |
NPD920 |
Approved |
0.7987 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7959 |
Intermediate Similarity |
NPD411 |
Approved |
0.7958 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.795 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7947 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7947 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7947 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7947 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7935 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7902 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7901 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.787 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7862 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7853 |
Intermediate Similarity |
NPD919 |
Approved |
0.784 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7811 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1608 |
Approved |
0.774 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7738 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7724 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7718 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7682 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7682 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7673 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1283 |
Approved |
0.767 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7669 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7662 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7658 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7628 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7616 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7602 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD3764 |
Approved |
0.76 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD17 |
Approved |
0.7566 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7558 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD943 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7471 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1778 |
Approved |
0.744 |
Intermediate Similarity |
NPD1247 |
Approved |
0.744 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7431 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7419 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7386 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7383 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD4287 |
Approved |
0.736 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7346 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD37 |
Approved |
0.7325 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7321 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7305 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.726 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7258 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7247 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD2654 |
Approved |
0.723 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7213 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7198 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7189 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7189 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7181 |
Intermediate Similarity |
NPD3972 |
Approved |
0.716 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7158
|
Intermediate Similarity |
NPD4361 |
Phase 2 |